The European Rare DIsease Therapeutic Initiative :
A partnership between academic research institutions and pharmaceutical companies to promote therapeutic research on rare diseases
 |
An easieraccess to compounds developed by pharmaceutical companies to facilitate their pre-clinical evaluation for the treatment of rare diseases |
|
4 pharmaceutical partners : GSK, Roche, Sanofi-Aventis, Servier. |
|
10 European academic institutions supporting ERDITI |
The ERDITI initiative is temporarily on hold. Please contact the GIS Institute for rare diseases for further information.
|
